Stockholders of Calyxt have voted in favour of all proposals regarding the merger of Calyxt and Cibus, which was announced earlier this year (see AgbioNews Jan 17, 2023). The merger is scheduled to close on or around Wednesday, May 31, 2023, subject to the satisfaction of the remaining closing conditions. Following the merger's closing, the new entity is expected to be renamed Cibus Inc., trade on the Nasdaq Capital Market under the ticker symbol ‘CBUS’ and be led by Cibus’ existing management team.

Calyxt also announced that it will effect a 1-for-5 reverse stock split of its common stock that is expected to occur at the same time as the anticipated closing date of the merger. When the reverse stock split is effective, every five shares of Calyxt’s common stock issued and outstanding or held as treasury shares as of the effective date will be automatically combined into one share of Calyxt common stock. The reverse stock split will not affect the number of shares of Calyxt common stock authorised for issuance or the par value of the company’s common stock.